Company
Code Bio
Pioneering Targeted Delivery of Genetic Medicines
Also known as Code Biotherapeutics
- Business model
- B2B
- Legal name
- Code Biotherapeutics
- codebiotx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Code Bio is a preclinical stage company developing novel genetic medicines.
Funding snapshot
- Total raised
- $85MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series A, $75M2022-06-07
Funding rounds
- Series A
- $75M2022-06-07, Company stated
- Round, 2022
- $37.5M2022-05-25, SEC form D sold, 10 investors
- Seed
- $10M2021-04-20, Company stated
- Round, 2021
- $10M2021-03-02, SEC form D sold, 6 investors
Products
- Web
- 3DNA®
Loading relationship preview